Back to results

The Open University

Studies on the specificities of <i>In Vivo</i> and <i>In Vitro</i> bioassays used in the potency determination of Therapeutic Erythropoietin

Abstract

dc:description.abstract

Erythropoietin (Epo), a kidney-produced cytokine, promotes the proliferation and differentiation of erythroid progenitors into mature red blood cells.<br></br><br></br>The <i>in vivo</i> biological activity of Epo is dependent on it being adequately glycosylated. Glycosylation is a variable process and its precise effect on clearance mechanisms within the body has yet to be fully established. Studies have shown, however, that the loss of the terminal sialic acid residue, leading to exposure of the penultimate galactose residue, results in a dramatic reduction in activity, owing to the liver's galactose-dependent clearing action. Current <i>in vitro</i> cell-based bioassays for Epo are unaffected by such a phenomenon and therefore do not correlate with the invivo bioassays.<br></br><br></br>As part of this project, strategies were devised for rendering cell-based bioassays sensitive to sialylation. The strategies' common feature was the inclusion of a mechanism for depleting or sequestering desialylated Epo via a galactose-binding protein (derived from either plants or the human liver). The assays were tested usinga range of Epo samples desialylated to various degrees by neuraminidase treatment. This provided proof of principle that rational manipulation of <i>in vitro</i> hioassays rendering them sensitive to a factor known to affect <i>in vivo</i> activity can allow the prediction of bioactivity without the use of live animals.<br></br><br></br>Two Epo sample sets were investigated in addition to the neuraminidase-treated sample set - one produced by different culture and purification procedures, the other consisting of a batch of pharmaceutical-grade Epo separated into fractions by ion-exchange HPLC. Investigations were carried out by means of the most sensitive assay developed as well as a range of biological, biochemical and physico-chemical techniques with a view to producing an analytical and comparative study. The results suggested that the relationship between galactose exposure and <i>in vivo</i> biological activity might not be as straightforward as had been initially thought.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
The Open University
Year dc:date.issued
2006

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Liefooghe, Emily Claire

Rights

Language dc:language
en

Chain of custody

source
Harvested from
The Open University
Base URL
oro.open.ac.uk/cgi/oai2
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Liefooghe, Emily Claire. Studies on the specificities of <i>In Vivo</i> and <i>In Vitro</i> bioassays used in the potency determination of Therapeutic Erythropoietin. doctoral thesis, The Open University, 2006.